Would you have Respiratory Rate Increased when you have Copd?

Summary

Respiratory rate increased is found among people with Copd, especially for people who are female, 60+ old, take medication Spiriva and have Chronic obstructive pulmonary disease. We study 40 people who have Respiratory rate increased and Copd from FDA and social media. Find out below who they are, other conditions they have and drugs they take.

You are not alone

Join a support group for people who have Copd and Respiratory rate increased >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Copd

Copd (chronic obstructive pulmonary disease) can be treated by Spiriva, Symbicort, Advair diskus 250/50, Prednisone, Albuterol sulfate (latest reports from 58,846 Copd patients)

Respiratory Rate Increased

Respiratory rate increased (excess breathing rate/min) has been reported by people with multi-organ failure (latest reports from 5,695 Respiratory rate increased patients).

On Aug, 21, 2016

40 people who have Copd and Respiratory Rate Increased are studied.


Number of reports submitted per year:

Would you have Respiratory rate increased when you have Copd?

Gender of people who have Copd and experience Respiratory Rate Increased *:

  • female: 55 %
  • male: 45 %

Age of people who have Copd and experience Respiratory Rate Increased *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 2.7 %
  • 40-49: 5.41 %
  • 50-59: 8.11 %
  • 60+: 83.78 %

Top co-existing conditions for these people *:

  • Chronic Obstructive Pulmonary Disease (40 people)
  • Hypertension (4 people)
  • Gastrooesophageal Reflux Disease (4 people)
  • Bipolar I Disorder (3 people)
  • Bipolar Disorder (3 people)
  • Atrial Fibrillation (3 people)
  • Asthma (3 people)
  • Affective Disorder (3 people)
  • Pain (2 people)
  • Emphysema (2 people)

Most common drugs for these people *:

  • Spiriva (16 people)
  • Advair Diskus 100/50 (7 people)
  • Combivent (6 people)
  • Aspirin (6 people)
  • Symbicort (5 people)
  • Albuterol (5 people)
  • Nexium (4 people)
  • Furosemide (4 people)
  • Acetaminophen (4 people)
  • Ventolin (3 people)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Respiratory rate increased and Copd?

Browse all symptoms of Copd

a b c d e f g h i j k l m n o p q r s t u v w x y z

Could your drugs cause Respiratory rate increased

Respiratory rate increased

Other conditions that could case Respiratory rate increased

Respiratory rate increased

Can you answer these questions?

More questions for: Copd, Respiratory rate increased

You may be interested in these reviews

More reviews for: Copd, Respiratory rate increased


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.